ENOVATIVE LAB, LLC – Trademark Portfolio

Entity Type: 16

ENOVATIVE LAB, LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include APPOINTPAL and COLLECTDESK. The owner is based in BOSTON, MA.

315 A ST.

BOSTON, MA 02210

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ENOVATIVE LAB, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

36
Insurance & Financial (1 filing)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does ENOVATIVE LAB, LLC have?

ENOVATIVE LAB, LLC has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 1 abandoned, 2 cancelled.

What trademark classes does ENOVATIVE LAB, LLC file in?

ENOVATIVE LAB, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.

What are ENOVATIVE LAB, LLC's most well-known trademarks?

ENOVATIVE LAB, LLC's registered trademark portfolio includes well-known marks such as APPOINTPAL and COLLECTDESK. These are among 2 currently registered trademarks in the portfolio.

What is ENOVATIVE LAB, LLC's trademark registration success rate?

ENOVATIVE LAB, LLC has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.